Добро пожаловать
Нажатие «Авторизоваться» означает, что вы соглашаетесь с Условия использования и политика конфиденциальности Cointime.
Зарегистрировать аккаунт
Аккаунт уже существует?
Нажатие «page.Sign up» означает, что вы соглашаетесь с <a class="underline" href="#term-of-service">Условия использования</a> и a class="underline" href="#privacy-policy">политика конфиденциальности</a> Cointime.
Войдите, используя email
Зарегистрируйтесь с помощью email
твой почтовый ящик
Проверь свои входящие
Нажмите на ссылку в , чтобы войти.
Нажмите на ссылку в , чтобы зарегистрироваться.
Alpana Ventures
company
About
Alpana Ventures is a leading Swiss VC focusing on digital transformation. Since 2016 we backed 45 founder teams with 3 Funds
- 1 - 10
Highlights
Details
- Industries
- Cyber Security,Enterprise Software,Finance,Financial Services,FinTech,Health Diagnostics,Venture Capital
- Founded date
- Jan 1, 2016
- Number Of Employee
- 1 - 10
- Operating Status
- Active
- Investor Type
- Venture Capital
Alpana Ventures is a Swiss VC focusing on digital transformation.Since 2016 we backed 45 founder teams with 3 Funds, supporting them in their journey towards a positive impact.Committed to value creation, we discover deep tech solutions in Switzerland, Europe and the US.We invest to embed them into innovative business models and back them to become global market leaders.Applying ESG criteria, our portfolio companies help create a more sustainable future.
Investments
Number of Investments
Number of Lead Investments
15
0
Alpana Ventures has made 15 investments. Their most recent investment was on
Nov 9, 2022, when Beekeeper raised $50M.
|
Date
Company Name
|
Round | Money Raised | Industry | Lead Investor |
|---|---|---|---|---|
|
Nov 9, 2022
Beekeeper
|
Series C | $50M | Enterprise Software | — |
|
Feb 25, 2022
IPwe
|
Series A | $2.48M | Cryptocurrency | — |
|
Nov 26, 2021
Beekeeper
|
Convertable Note | $10.50M | Enterprise Software | — |
|
Nov 8, 2021
Beekeeper
|
Series C | $50M | Enterprise Software | — |
|
Apr 10, 2021
DomoHealth
|
Series B | $3M | Clinical Trials | — |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
